HMCN1 c.10990-1674G>A

Variant ID: 1-186080270-G-A

NM_031935.2(HMCN1):c.10990-1674G>A

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Liquid biopsy leads to a paradigm shift in the treatment of pancreatic cancer.

World Journal Of Gastroenterology
Watanabe, Fumiaki F; Suzuki, Koichi K; Noda, Hiroshi H; Rikiyama, Toshiki T
Publication Date: 2022-12-14

Variant appearance in text: rs12061681
PubMed Link: 36569270
Variant Present in the following documents:
  • WJG-28-6478.pdf
View BVdb publication page



Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM).

Cancers
Silvestris, Nicola N; Brunetti, Oronzo O; Bittoni, Alessandro A; Cataldo, Ivana I; Corsi, Domenico D; Crippa, Stefano S; D'Onofrio, Mirko M; Fiore, Michele M; Giommoni, Elisa E; Milella, Michele M; Pezzilli, Raffaele R; Vasile, Enrico E; Reni, Michele M
Publication Date: 2020-06-24

Variant appearance in text: rs12061681
PubMed Link: 32599886
Variant Present in the following documents:
  • Main text
  • cancers-12-01681.pdf
View BVdb publication page